Gradient Investments LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 89 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$0
-100.0%
2,0000.0%0.00%
Q4 2021$1,0000.0%2,0000.0%0.00%
Q3 2021$1,000
-50.0%
2,0000.0%0.00%
Q2 2021$2,000
-33.3%
2,0000.0%0.00%
Q1 2021$3,000
+50.0%
2,0000.0%0.00%
Q4 2020$2,0000.0%2,0000.0%0.00%
Q3 2020$2,0002,0000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 676,761$751,0000.08%
Virtu Financial LLC 294,771$327,0000.03%
MONECO Advisors, LLC 35,000$39,0000.02%
Game Plan Financial Advisors, LLC 22,216$25,0000.02%
Purus Wealth Management, LLC 15,000$17,0000.01%
Renaissance Technologies 7,203,677$7,996,0000.01%
WINTON GROUP Ltd 122,987$137,0000.01%
LINCOLN CAPITAL CORP 10,000$11,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 214,500$238,0000.00%
FIRST MIDWEST BANK TRUST DIVISION 25,000$28,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders